Mr. Lang joined the Company as a director in January 2017. In May 2017, Mr. Lang founded and became the Chief Executive Officer and a director of Eversana Life Science Services, LLC, a leading provider of global commercialization services to the life sciences industry. In December 2025, he stepped down as the Chief Executive Officer but remains as a director of EVERSANA. Since December 2016, Mr. Lang has also served as an Executive Advisor to Water Street Healthcare Partners, a private equity firm focused on building healthcare companies. From 2012 to 2016, Mr. Lang served in leadership roles at Decision Resources Group (DRG), a global provider of data, analytics and consulting services to healthcare organizations, including as its Chief Executive Officer from 2014 to 2016. Earlier in his career, Mr. Lang held leadership roles at several global consulting and strategy firms. From 2006 to 2008, he served as President of IHS Cambridge Energy Research Associates, an international research and consulting firm providing analysis on energy markets, geopolitics and industry trends. From 1989 to 2006, he held various roles at Strategic Decisions Group, a global strategy consulting firm, including as President and Chief Operating Officer from 2000 to 2006. Mr. Lang currently serves on the board of directors of EVERSANA, BioVie Inc., a publicly traded clinical-stage biopharmaceutical company, Halozyme, a publicly traded leading drug delivery technology company, and PatientPoint, a leading point-of-care company. Mr. Lang brings more than 30 years of leadership experience in healthcare data, analytics and technology-enabled business services and is qualified to serve on our Board because of his extensive executive skills and background in the healthcare industry.